Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE1680.0077.75 (+4.85 %)

PREV CLOSE ( ) 1602.25

OPEN PRICE ( ) 1578.00

BID PRICE (QTY) 1679.10 (10)

OFFER PRICE (QTY) 1680.00 (55)

VOLUME 21460

TODAY'S LOW / HIGH ( )1577.65 1682.35

52 WK LOW / HIGH ( )417.65 1729.95

NSE1690.9080.2 (+4.98 %)

PREV CLOSE( ) 1610.70

OPEN PRICE ( ) 1571.00

BID PRICE (QTY) 1690.20 (55)

OFFER PRICE (QTY) 1690.90 (1)

VOLUME 190505

TODAY'S LOW / HIGH( ) 1571.00 1691.20

52 WK LOW / HIGH ( )416 1736.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1989

Management Info

Pawan Chaudhary - Chairman Pawan Chaudhary - Managing Director

Registered Office

Address S. C. O. 857, C. No. 10,2nd Floor,N A C Manimajra,
Chandigarh,
Union Territory-160101

Phone 0172-2561244/5577

Email info@venusremedies.com

Website www.venusremedies.com / www.vmrcindia.com

Registrars Details

MUFG Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

05Jun Venus Remedies touches roof on securin
Venus Remedies is currently trading at upper limit of Rs. 1637.10, up by..

04Jun Venus Remedies secures renewal of DSIR
Venus Remedies has secured the renewal of in-house Research & Develo..

22May Venus Remedies gets marketing authoriz
Venus Remedies has received Marketing Authorization from the Saudi Food..

22May Venus Remedies touches roof on getting
Venus Remedies is currently locked its upper circuit at Rs. 1082.95, up..

04May Venus Remedies informs about updates
Venus Remedies has informed that the links of the posts made on the offi..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 26
Net Profit	434.5	993.099999999999
Gross Profit	575.6	1306.8
Operating Profit	640.6	1553.7
Net Sales	2590.1	7687.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 26354.85 (0.80%)	M.Cap ( in Cr)56242.44
Kwality Pharma (BSE) 2493.75 (6.74%)	M.Cap ( in Cr)2651.12
Caplin Point Lab (BSE) 2350.00 (4.09%)	M.Cap ( in Cr)17988.55
Concord Biotech (BSE) 1336.50 (5.11%)	M.Cap ( in Cr)14049.43
Unichem Lab (BSE) 440.25 (16.45%)	M.Cap ( in Cr)3101.37

Shareholding Pattern

	NON-INSTITUTION	54.24%
	PROMOTERS	41.76%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

VENUS REMEDIES LTD.